GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » THC Therapeutics Inc (OTCPK:THCT) » Definitions » Operating Margin %

THC Therapeutics (THC Therapeutics) Operating Margin % : 0.00% (As of Jul. 2023)


View and export this data going back to 2007. Start your Free Trial

What is THC Therapeutics Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. THC Therapeutics's Operating Income for the three months ended in Jul. 2023 was $-0.06 Mil. THC Therapeutics's Revenue for the three months ended in Jul. 2023 was $0.00 Mil. Therefore, THC Therapeutics's Operating Margin % for the quarter that ended in Jul. 2023 was 0.00%.

The historical rank and industry rank for THC Therapeutics's Operating Margin % or its related term are showing as below:


THCT's Operating Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 6.13
* Ranked among companies with meaningful Operating Margin % only.

THC Therapeutics's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

THC Therapeutics's Operating Income for the three months ended in Jul. 2023 was $-0.06 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jul. 2023 was $-0.50 Mil.


THC Therapeutics Operating Margin % Historical Data

The historical data trend for THC Therapeutics's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

THC Therapeutics Operating Margin % Chart

THC Therapeutics Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

THC Therapeutics Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of THC Therapeutics's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, THC Therapeutics's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


THC Therapeutics's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, THC Therapeutics's Operating Margin % distribution charts can be found below:

* The bar in red indicates where THC Therapeutics's Operating Margin % falls into.



THC Therapeutics Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

THC Therapeutics's Operating Margin % for the fiscal year that ended in Jul. 2023 is calculated as

Operating Margin %=Operating Income (A: Jul. 2023 ) / Revenue (A: Jul. 2023 )
=-0.494 / 0
= %

THC Therapeutics's Operating Margin % for the quarter that ended in Jul. 2023 is calculated as

Operating Margin %=Operating Income (Q: Jul. 2023 ) / Revenue (Q: Jul. 2023 )
=-0.055 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


THC Therapeutics  (OTCPK:THCT) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


THC Therapeutics Operating Margin % Related Terms

Thank you for viewing the detailed overview of THC Therapeutics's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


THC Therapeutics (THC Therapeutics) Business Description

Traded in Other Exchanges
N/A
Address
11700 W Charleston Boulevard, No. 73, Las Vegas, NV, USA, 89135
Website
THC Therapeutics Inc is a United States-based company. It is focused on developing dHydronator, a sanitizing herb dryer. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis. It will reduce the drying time for cannabis from 10-14 days down to less than 14 hours.
Executives
Hiro Tanaka director, officer: Vice President 3RD FLOOR, 207 REGENT STREET, LONDON X0 W1B 3HH
Smith Adrian J R director, officer: Chair of the Board 119 SPRINGLINE DRIVE, VERO BEACH FL 32963
Jamie Mann director, 10 percent owner, officer: CEO, CFO 3RD FLOOR, 207 REGENT STREET, LONDON X0 W1B 3HH
Eden Ho director, officer: CEO 701 XUANG MI HU ROAD, XI YUAN, FUTIAN, SHENZHEN F4 XXXXXX